Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Katherine Monti"'
Autor:
Elizabeth E. Kim, Benjamin Solomon, Keith D. Wilner, Yiyun Tang, Sai-Hong Ignatius Ou, Katherine Monti, Maria Winter, Sherry C. Wang
Publikováno v:
Lung Cancer. 145:167-172
Objectives During crizotinib clinical evaluation, visual disturbances, generally of grade 1 severity, were frequently reported adverse events (AE). Consequently, ophthalmologic assessments were included in a patient subgroup enrolled in PROFILE 1001
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3afd6887ab153bab0cfb8e5f1773307a
https://doi.org/10.1016/j.lungcan.2020.04.010
https://doi.org/10.1016/j.lungcan.2020.04.010
Autor:
Jennifer Canniff, Amy S. Paller, Katherine Monti, Brett Jepson, Jon M. Hanifin, Donald Y.M. Leung, Gloria David, Adriana Weinberg, Lynda C. Schneider, Margarita Gomez Lorenzo, Lisa A. Beck
Publikováno v:
The Journal of allergy and clinical immunology. 139(5)
Background Antibody responses to the inactivated seasonal influenza vaccine in patients with atopic dermatitis (AD) have not been carefully characterized. Objective The primary objective of this study was to compare antibody responses to intradermal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5406c83b5697c8b8fdc7d0daf61156e8
https://pubmed.ncbi.nlm.nih.gov/28209343
https://pubmed.ncbi.nlm.nih.gov/28209343
Autor:
A. Drilon, Paul K. Paik, Sai-Hong Ou, Jared Weiss, Geoffrey I. Shapiro, Sherry C. Wang, Benjamin Solomon, Rebecca S. Heist, Katherine Monti, Gregory J. Riely, Keith D. Wilner, Mark A. Socinski, Maria Winter, D. Ross Camidge, Jeffrey W. Clark
Publikováno v:
Journal of Thoracic Oncology. 12:S438-S439
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96065f8a71e63f675d2b37b153dabfde
https://doi.org/10.1016/j.jtho.2016.11.512
https://doi.org/10.1016/j.jtho.2016.11.512
Autor:
Sai-Hong Ignatius Ou, Jeffrey W. Clark, Jared Weiss, D. Ross Camidge, Paul K. Paik, Mark A. Socinski, Alexander Drilon, Gregory J. Riely, Sherry C. Wang, Maria Winter, Keith D. Wilner, Katherine Monti
Publikováno v:
Journal of Clinical Oncology. 34:108-108
108Background: MET alterations leading to exon 14 skipping occur in ~4% of lung carcinomas, resulting in MET activation and sensitivity to MET inhibitors in vitro. Crizotinib, initially developed as a MET inhibitor, is currently approved for the trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::752b285d00aa8b1ccb031546b4a780f2
https://doi.org/10.1200/jco.2016.34.15_suppl.108
https://doi.org/10.1200/jco.2016.34.15_suppl.108
Publikováno v:
Amstat News. Mar2023, Issue 549, p23-26. 4p.
Publikováno v:
Amstat News. May2024, Issue 563, p3-4. 2p.
Publikováno v:
Amstat News. Jan2020, Issue 511, p5-6. 2p.